Joanne Wuensch
Stock Analyst at Citigroup
(4.35)
# 464
Out of 4,413 analysts
270
Total ratings
62.61%
Success rate
11.25%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $79 → $85 | $72.21 | +17.71% | 11 | Apr 25, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $134 → $140 | $119.56 | +17.10% | 19 | Apr 3, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $31 → $38 | $36.20 | +4.97% | 10 | Apr 3, 2024 | |
| SYK Stryker | Maintains: Buy | $362 → $406 | $328.12 | +23.74% | 9 | Apr 3, 2024 | |
| NVRO Nevro | Maintains: Neutral | $18 → $16 | $10.41 | +53.70% | 10 | Apr 3, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $428 → $462 | $371.70 | +24.29% | 12 | Apr 3, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $88 → $103 | $78.26 | +31.61% | 2 | Apr 3, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $49 → $60 | $50.61 | +18.55% | 2 | Apr 3, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $90 → $98 | $84.30 | +16.25% | 15 | Apr 3, 2024 | |
| DXCM DexCom | Maintains: Buy | $148 → $161 | $125.88 | +27.90% | 9 | Apr 3, 2024 | |
| COO The Cooper Companies | Maintains: Buy | $108 → $116 | $89.66 | +29.38% | 18 | Apr 3, 2024 | |
| BAX Baxter International | Maintains: Neutral | $41 → $44 | $40.34 | +9.07% | 11 | Apr 3, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $126 → $128 | $106.29 | +20.43% | 14 | Apr 3, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | $38 | $29.18 | +30.23% | 5 | Apr 3, 2024 | |
| GKOS Glaukos | Maintains: Buy | $107 → $120 | $98.91 | +21.32% | 16 | Mar 25, 2024 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $17 | $7.72 | +120.21% | 9 | Feb 23, 2024 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $110 | $111.74 | -1.56% | 15 | Dec 11, 2023 | |
| SILK Silk Road Medical | Downgrades: Sell | $35 → $8 | $20.16 | -60.32% | 10 | Oct 11, 2023 | |
| HAE Haemonetics | Maintains: Neutral | $90 → $94 | $92.13 | +2.03% | 6 | Oct 2, 2023 | |
| PEN Penumbra | Maintains: Buy | $390 → $320 | $205.29 | +55.88% | 18 | Oct 2, 2023 | |
| SGHT Sight Sciences | Maintains: Neutral | $8 → $4 | $5.59 | -28.44% | 7 | Sep 15, 2023 | |
| PODD Insulet | Upgrades: Buy | $273 → $265 | $170.27 | +55.64% | 9 | Aug 21, 2023 | |
| BLCO Bausch + Lomb | Maintains: Buy | $22 → $23 | $13.74 | +67.39% | 2 | Jul 10, 2023 | |
| JNJ Johnson & Johnson | Reinstates: Buy | $185 | $151.18 | +22.37% | 9 | May 30, 2023 | |
| ITGR Integer Holdings | Initiates: Neutral | $88 | $109.78 | -19.84% | 1 | May 11, 2023 | |
| BDX Becton, Dickinson and Company | Upgrades: Neutral | $220 → $250 | $233.72 | +6.97% | 4 | Dec 12, 2022 | |
| MDT Medtronic | Downgrades: Neutral | $108 → $85 | $80.89 | +5.08% | 9 | Nov 23, 2022 | |
| ALC Alcon | Maintains: Neutral | $67 → $69 | $78.53 | -12.14% | 4 | Nov 17, 2022 | |
| RMD ResMed | Upgrades: Outperform | n/a | $215.01 | - | 4 | Dec 10, 2018 |
Boston Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $79 → $85
Current: $72.21
Upside: +17.71%
Zimmer Biomet Holdings
Apr 3, 2024
Maintains: Neutral
Price Target: $134 → $140
Current: $119.56
Upside: +17.10%
Tandem Diabetes Care
Apr 3, 2024
Maintains: Neutral
Price Target: $31 → $38
Current: $36.20
Upside: +4.97%
Stryker
Apr 3, 2024
Maintains: Buy
Price Target: $362 → $406
Current: $328.12
Upside: +23.74%
Nevro
Apr 3, 2024
Maintains: Neutral
Price Target: $18 → $16
Current: $10.41
Upside: +53.70%
Intuitive Surgical
Apr 3, 2024
Maintains: Buy
Price Target: $428 → $462
Current: $371.70
Upside: +24.29%
GE HealthCare Technologies
Apr 3, 2024
Maintains: Buy
Price Target: $88 → $103
Current: $78.26
Upside: +31.61%
Establishment Labs Holdings
Apr 3, 2024
Maintains: Buy
Price Target: $49 → $60
Current: $50.61
Upside: +18.55%
Edwards Lifesciences
Apr 3, 2024
Maintains: Neutral
Price Target: $90 → $98
Current: $84.30
Upside: +16.25%
DexCom
Apr 3, 2024
Maintains: Buy
Price Target: $148 → $161
Current: $125.88
Upside: +27.90%
The Cooper Companies
Apr 3, 2024
Maintains: Buy
Price Target: $108 → $116
Current: $89.66
Upside: +29.38%
Baxter International
Apr 3, 2024
Maintains: Neutral
Price Target: $41 → $44
Current: $40.34
Upside: +9.07%
Abbott Laboratories
Apr 3, 2024
Maintains: Buy
Price Target: $126 → $128
Current: $106.29
Upside: +20.43%
Integra LifeSciences Holdings
Apr 3, 2024
Upgrades: Neutral
Price Target: $38
Current: $29.18
Upside: +30.23%
Glaukos
Mar 25, 2024
Maintains: Buy
Price Target: $107 → $120
Current: $98.91
Upside: +21.32%
Pulmonx
Feb 23, 2024
Maintains: Buy
Price Target: $16 → $17
Current: $7.72
Upside: +120.21%
iRhythm Technologies
Dec 11, 2023
Upgrades: Buy
Price Target: $110
Current: $111.74
Upside: -1.56%
Silk Road Medical
Oct 11, 2023
Downgrades: Sell
Price Target: $35 → $8
Current: $20.16
Upside: -60.32%
Haemonetics
Oct 2, 2023
Maintains: Neutral
Price Target: $90 → $94
Current: $92.13
Upside: +2.03%
Penumbra
Oct 2, 2023
Maintains: Buy
Price Target: $390 → $320
Current: $205.29
Upside: +55.88%
Sight Sciences
Sep 15, 2023
Maintains: Neutral
Price Target: $8 → $4
Current: $5.59
Upside: -28.44%
Insulet
Aug 21, 2023
Upgrades: Buy
Price Target: $273 → $265
Current: $170.27
Upside: +55.64%
Bausch + Lomb
Jul 10, 2023
Maintains: Buy
Price Target: $22 → $23
Current: $13.74
Upside: +67.39%
Johnson & Johnson
May 30, 2023
Reinstates: Buy
Price Target: $185
Current: $151.18
Upside: +22.37%
Integer Holdings
May 11, 2023
Initiates: Neutral
Price Target: $88
Current: $109.78
Upside: -19.84%
Becton, Dickinson and Company
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $233.72
Upside: +6.97%
Medtronic
Nov 23, 2022
Downgrades: Neutral
Price Target: $108 → $85
Current: $80.89
Upside: +5.08%
Alcon
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $78.53
Upside: -12.14%
ResMed
Dec 10, 2018
Upgrades: Outperform
Price Target: n/a
Current: $215.01
Upside: -